AI assistant
Sending…
ImmunityBio, Inc. — Director's Dealing 2015
Aug 11, 2015
31529_dirs_2015-08-11_e913d224-6fc4-4c5c-b5fa-187ab20802ce.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: NantKwest, Inc. (NK)
CIK: 0001326110
Period of Report: 2015-07-27
Reporting Person: BLASZYK MICHAEL D (Director)
More from ImmunityBio, Inc.
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 7
Regulatory Filings
2026
Apr 9
Regulatory Filings
2026
Apr 6
Regulatory Filings
2026
Mar 31
Director's Dealing
2026
Feb 26
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 24